# STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation

> **NCT03184805** · NA · TERMINATED · sponsor: **Yonsei University** · enrollment: 140 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Continuing aspirin
- **DRUG:** Stopping aspirin

## Key facts

- **NCT ID:** NCT03184805
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-23
- **Primary completion:** 2018-04-09
- **Final completion:** 2018-04-09
- **Target enrollment:** 140 (ACTUAL)
- **Why stopped:** Investigator judged that this study can not be maintained because participant registration rate is low.
- **Last updated:** 2018-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03184805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03184805, "STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03184805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*